Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) Patients
NCT00969306
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
5
Enrollment
OTHER
Sponsor class
Stopped
Poor accrual
Conditions
Small Cell Lung Cancer
Interventions
DRUG:
Chloroquine, A-CQ 100
Sponsor
Maastricht Radiation Oncology
Collaborators
[object Object]
[object Object]